EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

What You Should Know: – EVERSANA and Waltz Health have announced a merger valued at $6B to form a unified healthcare platform that will redefine pharmaceutical commercialization and patient access. – The merger combines Waltz Health’s software-powered drug-price marketplaces and direct-to-payer model with EVERSANA’s global commercialization services. The new organization aims to deliver a next-generation ... Read More